Matinas BioPharma Holdings, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

STATEMENT OF STOCKHOLDER'S EQUITY

STATEMENT OF STOCKHOLDER'S EQUITY (USD $)	Total	Redeemable Convertible Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]
Balance at Dec. 31, 2012	$ (116,592)us-gaap_StockholdersEquity	$ 456,528	$ 1,000	$ 0	$ (117,592)
Balance (in shares) at Dec. 31, 2012		925,926	10,000,000
Sale of Preferred Stock		500,001
Sale of Preferred Stock (in shares)		925,926
Issuance cost paid in connection of sale of preferred stock		(4,140)
Formation of Matinas BioPharma Holdings (July 11, 2013)	375,000		750	374,250
Formation of Matinas BioPharma Holdings (July 11, 2013) (in shares)			7,500,000
Elimination of Matinas BioPharma Inc. Equity (July 11, 2013)	(1,000)	(952,389)	(1,000)
Elimination of Matinas BioPharma Inc. Equity (July 11, 2013) (in shares)		(1,851,852)	(10,000,000)
Issuance of shares in Matinas Holdings to former shareholders of Matinas BioPharma Inc	953,389		900	952,489
Issuance of shares in Matinas Holdings to former shareholders of Matinas BioPharma Inc (in shares)			9,000,000
Sale of warrants	138,316			138,316
Private Placement ( July 30, 2013 and August 8, 2013)	15,000,000		1,500	14,998,500
Private Placement ( July 30, 2013 and August 8, 2013) (in shares)			15,000,000
Private Placement Issuance Costs	(2,378,672)			(2,378,672)
Restricted Stock Grant to non-employee	470,000		50	469,950
Restricted Stock Grant to non-employee (in shares)			500,000
Restricted Stock for services to be rendered	(463,562)			(463,562)
Stock Based Compensation	211,036			211,036
Net loss	(3,713,127)us-gaap_NetIncomeLoss				(3,713,127)
Balance at Dec. 31, 2013	10,474,788us-gaap_StockholdersEquity	0	3,200	14,302,307	(3,830,719)
Balance (in shares) at Dec. 31, 2013		0	32,000,000
Stock Based Compensation	1,821,402			1,821,402
Issuance of Common Stock for services	152,751		30	152,721
Issuance of Common Stock for services (in shares)			292,650
Net loss	(10,221,045)us-gaap_NetIncomeLoss				(10,221,045)
Balance at Dec. 31, 2014	2,227,896us-gaap_StockholdersEquity	0	3,230	16,276,430	(14,051,764)
Balance (in shares) at Dec. 31, 2014		0	32,292,650
Aquarius Inc. Purchase January 29, 2015	2,119,689		461	2,119,229
Aquarius Inc. Purchase January 29, 2015 (in shares)			4,608,020
First Closing of Private Placement March 31, 2015, including Placement Agent Warrants	4,282,734		988	4,281,746
First Closing of Private Placement March 31, 2015, including Placement Agent Warrants (in shares)			9,875,000
Stock Based Compensation	332,683			332,683
Net loss	(2,570,111)us-gaap_NetIncomeLoss				(2,570,111)
Balance at Mar. 31, 2015	$ 6,392,892us-gaap_StockholdersEquity	$ 0	$ 4,679	$ 23,010,088	$ (16,621,875)
Balance (in shares) at Mar. 31, 2015		0	46,775,670